Approximately 100,000 individuals in the United States are affected by idiopathic pulmonary fibrosis. Should these patients all receive anti-fibrotic therapy? Share your thoughts by taking this poll.
There has been debate over the effectiveness and safety of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease. Is the therapy one that you would use among your patients?
Interstitial lung diseases are characterized by fibrosis in the lungs. However, they do not always only affect the lungs. Which ILD causes skin lesions? Take this Pop Quiz to find out.
It has been debated whether epinephrine can improve patient outcomes in critical care settings. How much epinephrine do you administer? And do you administer through a bolus or a drip? Let your opinion be...
Low-dose computed tomography scanning is recommended for screening high-risk individuals for lung cancer. Do you think the same method can or should be used for managing COPD?